Tag: CpG

Programmable local immunochemotherapy for triple-negative breast cancer via spatiotemporally controlled release of CpG oligodeoxynucleotides, gemcitabine, and paclitaxel

Programmable local immunochemotherapy for triple-negative breast cancer via spatiotemporally controlled release of CpG oligodeoxynucleotides, gemcitabine, and paclitaxel

Zagami, P. & Carey, L. A. Triple negative breast cancer: pitfalls and progress. NPJ Breast ...

READ MORE